BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6340869)

  • 21. Antigenic evaluation of mycobacterium vaccae in relation to Mycobacterium leprae.
    Navalkar RG; Chaparas SD; Lakshiminarayana CK; Kanchana MV
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):388-96. PubMed ID: 6782031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis.
    Baughn RE; McNeely MC; Jorizzo JL; Musher DM
    J Immunol; 1986 Feb; 136(4):1406-14. PubMed ID: 2418114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
    Brett SJ; Draper P; Payne SN; Rees RJ
    Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of circulating immune complexes of leprosy patients on leukocyte migration inhibition induced by Mycobacterium leprae antigens in healthy volunteers.
    Tyagi P; Girdhar BK; Katoch K; Sengupta V
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):487-92. PubMed ID: 1890375
    [No Abstract]   [Full Text] [Related]  

  • 26. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
    Melsom R; Harboe M; Duncan ME
    Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
    Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the antigenic profile of Mycobacterium leprae: cross-reactive and unique specificities of human and rabbit antibodies.
    Ehrenberg JP; Gebre N
    Scand J Immunol; 1987 Dec; 26(6):673-81. PubMed ID: 3321410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy.
    Wager O; Penttinen K; Almeida JD; Opromolla DV; Godal T; Kronvall G
    Clin Exp Immunol; 1978 Dec; 34(3):326-37. PubMed ID: 369750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dominant cell wall proteins of Mycobacterium leprae recognized by monoclonal antibodies.
    Britton WJ; Hellqvist L; Garsia RJ; Basten A
    Clin Exp Immunol; 1987 Jan; 67(1):31-42. PubMed ID: 3304738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of mycobacterial antigens in leprosy serum immune complex.
    Patil SA; Sinha S; Sengupta U
    J Clin Microbiol; 1986 Jul; 24(1):169-71. PubMed ID: 3088033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of mycobacterial antigens in leprosy tissues.
    Mshana RN; Belehu A; Stoner GL; Harboe M; Haregewoin A
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):1-10. PubMed ID: 7042609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Circulating immune complexes in lepromatous leprosy patients].
    Kuzina ZA; Mezhova LI; Vilkov GA; Khasabov LM
    Vestn Dermatol Venerol; 1983 May; (5):11-4. PubMed ID: 6349167
    [No Abstract]   [Full Text] [Related]  

  • 34. Serology of leprosy. II. Demonstration of specific antibodies to mycobacterium leprae by counter current electrophoresis.
    Jagannath C; Sengupta DN
    Lepr India; 1981 Oct; 53(4):513-7. PubMed ID: 7038297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
    Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
    Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy.
    Melsom R; Duncan ME; Harboe M; Bjune G
    Clin Exp Immunol; 1980 Oct; 42(1):107-13. PubMed ID: 7006873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoblotting and the immune response to leprosy.
    Young DB
    Biochem Soc Trans; 1988 Apr; 16(2):143-4. PubMed ID: 3286317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
    Segal-Eiras A; Croce MV; Ramos GS; Córsico B
    Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
    Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
    Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An assay for antibodies in leprosy sera reacting with ribonucleoprotein (RNP), a mycobacterial ribosomal antigen, using crossed immunoelectrophoresis with intermediate gel.
    Stoner GL; Touw J; Belehu A
    Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):247-53. PubMed ID: 6777312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.